Carisoprodol is discontinued (DEA controlled substance). Carisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands. It is slightly soluble in water and freely soluble in ethanol, chloroform and acetone. The drug's solubility is practically independent of pH. Although carisoprodol has significant pharmacological activity, its benefit in therapy is likely due mostly to the meprobamate metabolite as meprobamate remains in the system significantly longer and reaches a higher peak plasma concentration than the parent drug a few hours following administration. This is further evidenced by carisoprodol's ability to maintain relevant benefits when administered 3-4 times a day despite its short half-life of only two hours. References: Masoner JR, Kolpin DW, Furlong ET, Cozzarelli IM, Gray JL. Landfill leachate as a mirror of today's disposable society: Pharmaceuticals and other contaminants of emerging concern in final leachate from landfills in the conterminous United States. Environ Toxicol Chem. 2015 Nov 12. doi: 10.1002/etc.3219. [Epub ahead of print] PubMed PMID: 26562222.

纯度：≥98%

CAS：78-44-4